Anagenics Limited · ASX:AN1

Anagenics Limited financial statements

Anagenics Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in AUD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue5.16M4.75M10.8M9.11M6.95M5.82M7.38M7.30M5.65M4.50M
Cost of revenue2.35M2.71M6.44M5.06M3.15M2.11M2.53M2.14M5.62M4.83M
Gross profit2.81M2.04M4.36M4.05M3.80M3.70M4.85M5.16M27.9K-331.4K
Research and development8.68K21.2K26.2K118.8K849.0K848.5K598.5K599.6K
Selling, general and administrative2.02M2.50M7.87M4.12M118.9K64.8K5.18M5.38M3.67M2.78M
Operating income629.8K-1.32M-7.38M-1.92M-1.60M-3.64M-4.75M-5.65M-3.26M-4.14M
Depreciation and amortization186.2K200.4K616.3K359.8K495.5K434.6K518.7K152.9K187.5K168.5K
EBITDA816.1K-1.12M-6.76M-1.56M-1.10M-3.21M-4.23M-5.50M-3.07M-3.97M
Interest expense69.2K40.5K66.3K31.8K25.0K54.8K71.3K235.0K473.3K291.2K
Income before tax308.5K-1.24M-7.28M-2.20M-1.64M-3.76M-4.82M-5.89M-3.73M-4.43M
Income tax209.0K-454.7K15245.0K89.5K24.1K2.43K35.6K
Net income308.5K-1.24M-7.49M-2.67M-3.65M-3.39M-4.91M-5.91M-3.73M-4.47M
Earnings per share, basic0.00-0.00-0.02-0.01-0.02-0.02-0.05-0.07-0.06-0.08

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents577.4K395.5K1.62M2.57M3.28M6.73M6.97M3.08M1.61M3.99M
Receivables805.4K574.8K651.5K1.09M921.3K1.80M1.87M2.29M1.03M378.3K
Inventory1.03M967.7K1.48M2.40M4.45M2.55M2.61M1.62M1.18M2.08M
Current assets2.74M1.94M3.83M6.25M8.77M11.3M11.6M7.23M4.16M6.56M
Property, plant and equipment211.2K411.6K772.8K578.3K527.3K1.50M800.2K771.0K744.7K
Goodwill1.95M1.95M1.95M3.45M3.45M
Total assets4.75M4.10M6.19M11.1M12.9M13.3M14.9M9.79M6.75M8.47M
Accounts payable315.9K1.06M1.69M724.1K502.7K682.2K839.7K685.2K603.8K680.8K
Current liabilities520.8K2.19M3.17M1.71M3.66M1.92M3.48M2.91M3.72M3.76M
Long-term debt0767.5K601.4K1.03M1.02M1.17M314.6K
Total debt33.2K848.1K772.6K654.3K1.76M1.43M1.96M1.29M3.17M2.16M
Total liabilities520.8K2.28M3.48M2.22M4.64M2.86M5.08M3.93M4.89M4.08M
Shareholders' equity4.23M1.83M2.71M8.90M8.29M10.4M9.81M5.86M1.86M4.40M
Shares outstanding743.0M469.4M399.0M266.0M211.4M142.5M105.6M82.1M60.1M55.3M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-1.07M-1.58M-1.74M-1.78M-2.53M-4.11M-4.01M-5.93M-4.40M-4.06M
Capital spending-25.0K-3-97.9K-45.4K-35.9K-22.5K-22.5K-65.7K-107.2K-35.9K
Free cash flow-1.09M-1.58M-1.84M-1.83M-2.59M-22.5K-4.01M-6.00M-4.51M-4.10M
Cash from investing-25.0K0-197.9K-1.51M-968.2K477.5K477.5K-65.7K-214.1K-35.9K
Cash from financing1.28M345.4K993.7K2.56M73.3K3.50M7.98M7.27M2.19M5.44M
Dividends paid-271.4K-54.8K-202.2K
Share buybacks-150.9K0-149.3K-271.4K0-379.0K-535.8K-114.8K-27.0K4.07M
Change in cash181.9K-1.23M-943.1K-717.8K-3.44M-243.2K3.89M1.47M-2.39M1.31M